Aoxing Pharmaceutical Company (AXN)
Add to Watchlists Create an AlertAXN Key Stats
| Income Statement | |
| Revenue TTM | 10.40M |
| Revenue Quarterly YoY Growth | 56.04% |
| EPS Diluted TTM | -0.3627 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -18.02M |
| Profitability | |
| Gross Profit Margin Quarterly | 59.52% |
| Profit Margin Quarterly | -90.22% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 10.96M |
| Enterprise Value | 27.53M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 0.5828 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 1.068 |
| Free Cash Flow | -3.144M |
| Return on Equity | -66.03% |
AXN News
- Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarte... May 15
- AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q, Quarterly Report May 15
- AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Changes in Registrant's ... May 2
- Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Second Quart... Feb 15
- AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q, Quarterly Report Feb 14
- Aoxing Pharmaceutical Company, Inc. Announces Receipt Of Production License For ... Jan 28
- AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q/A, Quarterly Report Nov 30
- Aoxing Pharmaceutical Company, Inc. Announces Financial Results For First Quarte... Nov 14
- AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q, Quarterly Report Nov 14
- Aoxing Pharmaceutical Company, Inc. Announced Financial Results For 2012 Fiscal ... Oct 15
AXN Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Aoxing Pharmaceutical Company is down 42.11% over the last year vs S&P 500 Total Return up 28.68%, GlaxoSmithKline up 25.36%, and Tetraphase Pharmaceuticals up 0.62%.
AXN Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these AXN related companies
Pro Ratings for AXN
Pro Report PDF for AXN
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download AXN Pro Report PDF
Pro Strategies Featuring AXN
Did Aoxing Pharmaceutical Company make it into our Pro Portfolio Strategies?
AXN Profile
Sector: Healthcare
Industry: Drug Manufacturers - Major
Other AXN Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AXN | 0.22 | +0.01 | +2.33% | 10.96M |
